proximal rough surface-finished spectron ef stem (Spectron Corporation)
90
Structured Review
Spectron Corporation
proximal rough surface-finished spectron ef stem
Proximal Rough Surface Finished Spectron Ef Stem, supplied by Spectron Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proximal+rough+surface-finished+spectron+ef+stem/proximal+rough+surface+finished+spectron+ef+stem/pm16394756-3-11-10
Average 90 stars, based on 1 article reviews
Proximal Rough Surface Finished Spectron Ef Stem, supplied by Spectron Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proximal+rough+surface-finished+spectron+ef+stem/proximal+rough+surface+finished+spectron+ef+stem/pm16394756-3-11-10
Average 90 stars, based on 1 article reviews
proximal rough surface-finished spectron ef stem - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Infection:Article Title: Metallic shedding, surface finish changes, and extensive femoral osteolysis in the loose Spectron EF stem. Article Snippet: The addition of a proximal rough surface finish in the satin finish Spectron stem (Spectron EF) reportedly does not alter its clinical performance.. However, we have revised 15 Spectron EF stems because of aseptic loosening and extensive femoral osteolysis at early and intermediate-term followup, raising a question as to its safety.. We sought to determine which interface has aseptic failure, the presence of massive femoral osteolysis, and the consequences of loosening at the implant-cement interface in the implant’s surface finish. In Situ:Article Title: Metallic shedding, surface finish changes, and extensive femoral osteolysis in the loose Spectron EF stem. Article Snippet: The addition of a proximal rough surface finish in the satin finish Spectron stem (Spectron EF) reportedly does not alter its clinical performance.. However, we have revised 15 Spectron EF stems because of aseptic loosening and extensive femoral osteolysis at early and intermediate-term followup, raising a question as to its safety.. We sought to determine which interface has aseptic failure, the presence of massive femoral osteolysis, and the consequences of loosening at the implant-cement interface in the implant’s surface finish. |